Please find attached a press release by Chugai:
https://www.roche.com/180717_Chugai_In_licence_of_Entrectinib.pdf
Do not hesitate to contact us for any further questions.
With best regards,
| Roche Investor Relations | |
| Dr. Karl Mahler Phone: +41 61 68-78503 e-mail: karl.mahler@roche.com | Dr. Sabine Borngräber Phone: +41 61 68-88027 e-mail: sabine.borngraeber@roche.com |
| Dr. Bruno Eschli Phone: +41 61 68-75284 e-mail: bruno.eschli@roche.com | Dr. Susann Manchado Phone: +41 61-68-75619 e-mail: susann.manchado@roche.com |
| Dr. Birgit Masjost Phone: +41 61 68-84814 e-mail: birgit.masjost@roche.com | |
| Investor Relations North America | |
| Loren Kalm Phone: +1 650 225 3217 e-mail: kalm.loren@gene.com |
get the latest news and updates to your inbox.